This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Saetta, M. Articles by Fabbri, L. M. Search for Related Content PubMed PubMed Citation Articles by Saetta, M. Articles by Fabbri, L. M.

Increased Expression of the Chemokine Receptor CXCR3 and Its Ligand CXCL10 in Peripheral Airways of Smokers with Chronic Obstructive Pulmonary Disease

Department of Clinical and Experimental Medicine, Section of Respiratory Diseases, University of Padova, Padova; BioXell, Milan; Research Center on Asthma and COPD, University of Ferrara, Ferrara; and Department of Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy

Correspondence and requests for reprints should be addressed to Marina Saetta, Divisione di Pneumologia, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Padova, via Giustiniani 3, 35128 Padova, Italy. E-mail: marina.saetta{at}unipd.it

CXCR3 is a chemokine receptor preferentially expressed on lymphocytes, particularly on type-1 T-lymphocytes. Smokers who develop chronic obstructive pulmonary disease (COPD) have a chronic bronchopulmonary inflammation that is characterized by an increased infiltration of T-lymphocytes, particularly CD8⁺, in the airways and lung parenchyma. To investigate the expression of CXCR3 and its ligand interferon-induced protein 10/CXCL10 in COPD, we counted the number of CXCR3⁺ cells and analyzed the expression of CXCL10 in the peripheral airways of 19 patients undergoing lung resection for localized pulmonary lesions. We examined lung specimens from seven smokers with fixed airflow limitation (COPD), five smokers with normal lung function, and seven nonsmoking subjects with normal lung function. The number of CXCR3⁺ cells was immunohistochemically quantified in the epithelium, in the submucosa, and in the adventitia of peripheral airways. The number of CXCR3⁺ cells in the epithelium and submucosa was increased in smokers with COPD as compared with nonsmoking subjects, but not as compared with smokers with normal lung function. Immunoreactivity for the CXCR3-ligand CXCL10 was present in the bronchiolar epithelium of smokers with COPD but not in the bronchiolar epithelium of smoking and nonsmoking control subjects. Most CXCR3⁺ cells coexpressed CD8 and produced interferon . These findings suggest that the CXCR3/CXCL10 axis may be involved in the T cell recruitment that occurs in peripheral airways of smokers with COPD and that these T cells may have a type-1 profile.

Key Words: inflammation • type-1 lymphocytes • airflow limitation • smoking

This article has been cited by other articles:

				V. Kim, T. J. Rogers, and G. J. Criner New Concepts in the Pathobiology of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, May 1, 2008; 5(4): 478 - 485. [Abstract] [Full Text] [PDF]

				A. Churg, M. Cosio, and J. L. Wright Mechanisms of cigarette smoke-induced COPD: insights from animal models Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L612 - L631. [Abstract] [Full Text] [PDF]

				S. Baraldo and M. Saetta To reg or not to reg: that is the question in COPD Eur. Respir. J., March 1, 2008; 31(3): 486 - 488. [Full Text] [PDF]

				M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]

				L. M. Ayer, S. M. Wilson, S. L. Traves, D. Proud, and M. A. Giembycz 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-benzyl)-phenyl]-amine (RO1138452) Is a Selective, Pseudo-Irreversible Orthosteric Antagonist at the Prostacyclin (IP)-Receptor Expressed by Human Airway Epithelial Cells: IP-Receptor-Mediated Inhibition of CXCL9 and CXCL10 Release J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 815 - 826. [Abstract] [Full Text] [PDF]

				J. C. Porter, M. Falzon, and A. Hall Polarized Localization of Epithelial CXCL11 in Chronic Obstructive Pulmonary Disease and Mechanisms of T Cell Egression J. Immunol., February 1, 2008; 180(3): 1866 - 1877. [Abstract] [Full Text] [PDF]

				T. Renda, S. Baraldo, G. Pelaia, E. Bazzan, G. Turato, A. Papi, P. Maestrelli, R. Maselli, A. Vatrella, L. M. Fabbri, et al. Increased activation of p38 MAPK in COPD Eur. Respir. J., January 1, 2008; 31(1): 62 - 69. [Abstract] [Full Text] [PDF]

				C. Costa, R. Rufino, S. L. Traves, J. R. Lapa e Silva, P. J. Barnes, and L. E. Donnelly CXCR3 and CCR5 Chemokines in Induced Sputum From Patients With COPD Chest, January 1, 2008; 133(1): 26 - 33. [Abstract] [Full Text] [PDF]

				I. Sabroe, L. C. Parker, S. K. Dower, and M. K. B. Whyte Practical and Conceptual Models of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, December 1, 2007; 4(8): 606 - 610. [Abstract] [Full Text] [PDF]

				S. Baraldo, E. Bazzan, M. E. Zanin, G. Turato, S. Garbisa, P. Maestrelli, A. Papi, M. Miniati, L. M. Fabbri, R. Zuin, et al. Matrix Metalloproteinase-2 Protein in Lung Periphery Is Related to COPD Progression Chest, December 1, 2007; 132(6): 1733 - 1740. [Abstract] [Full Text] [PDF]

				S. J. Tudhope, M. C. Catley, P. S. Fenwick, R. E. K. Russell, W. L. Rumsey, R. Newton, P. J. Barnes, and L. E. Donnelly The Role of I{kappa}B Kinase 2, but Not Activation of NF-{kappa}B, in the Release of CXCR3 Ligands from IFN-{gamma}-Stimulated Human Bronchial Epithelial Cells J. Immunol., November 1, 2007; 179(9): 6237 - 6245. [Abstract] [Full Text] [PDF]

				J. L. Curtis, C. M. Freeman, and J. C. Hogg The Immunopathogenesis of Chronic Obstructive Pulmonary Disease: Insights from Recent Research Proceedings of the ATS, October 1, 2007; 4(7): 512 - 521. [Abstract] [Full Text] [PDF]

				C. M. Freeman, J. L. Curtis, and S. W. Chensue CC Chemokine Receptor 5 and CXC Chemokine Receptor 6 Expression by Lung CD8+ Cells Correlates with Chronic Obstructive Pulmonary Disease Severity Am. J. Pathol., September 1, 2007; 171(3): 767 - 776. [Abstract] [Full Text] [PDF]

				T. Maeno, A. M. Houghton, P. A. Quintero, S. Grumelli, C. A. Owen, and S. D. Shapiro CD8+ T Cells Are Required for Inflammation and Destruction in Cigarette Smoke-Induced Emphysema in Mice J. Immunol., June 15, 2007; 178(12): 8090 - 8096. [Abstract] [Full Text] [PDF]

				C Monteagudo, J M Martin, E Jorda, and A Llombart-Bosch CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors J. Clin. Pathol., June 1, 2007; 60(6): 596 - 599. [Abstract] [Full Text] [PDF]

				C. Pilette, B. Colinet, R. Kiss, S. Andre, H. Kaltner, H-J. Gabius, M. Delos, J-P. Vaerman, M. Decramer, and Y. Sibille Increased galectin-3 expression and intra-epithelial neutrophils in small airways in severe COPD Eur. Respir. J., May 1, 2007; 29(5): 914 - 922. [Abstract] [Full Text] [PDF]

				S. Ma, Y. Y. Lin, and G. M. Turino Measurements of Desmosine and Isodesmosine by Mass Spectrometry in COPD Chest, May 1, 2007; 131(5): 1363 - 1371. [Abstract] [Full Text] [PDF]

				J. H. J. Vernooy, G. M. Moller, R. J. van Suylen, M. P. van Spijk, R. H. E. Cloots, P. H. Hoet, H. J. Pennings, and E. F. M. Wouters Increased Granzyme A Expression in Type II Pneumocytes of Patients with Severe Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 464 - 472. [Abstract] [Full Text] [PDF]

				M.-J. Kang, R. J. Homer, A. Gallo, C. G. Lee, K. A. Crothers, S. J. Cho, C. Rochester, H. Cain, G. Chupp, H. J. Yoon, et al. IL-18 Is Induced and IL-18 Receptor {alpha} Plays a Critical Role in the Pathogenesis of Cigarette Smoke-Induced Pulmonary Emphysema and Inflammation J. Immunol., February 1, 2007; 178(3): 1948 - 1959. [Abstract] [Full Text] [PDF]

				A. Koch, M. Gaczkowski, G. Sturton, P. Staib, T. Schinkothe, E. Klein, A. Rubbert, K. Bacon, K. Wassermann, and E. Erdmann Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking Eur. Respir. J., January 1, 2007; 29(1): 42 - 50. [Abstract] [Full Text] [PDF]

				S. Boodoo, E. W. Spannhake, J. D. Powell, and M. R. Horton Differential regulation of hyaluronan-induced IL-8 and IP-10 in airway epithelial cells Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L479 - L486. [Abstract] [Full Text] [PDF]

				J. A. Elias, M. J. Kang, K. Crouthers, R. Homer, and C. G. Lee State of the Art. Mechanistic Heterogeneity in Chronic Obstructive Pulmonary Disease: Insights from Transgenic Mice Proceedings of the ATS, August 1, 2006; 3(6): 494 - 498. [Abstract] [Full Text] [PDF]

				P. J. Barnes, B. Chowdhury, S. A. Kharitonov, H. Magnussen, C. P. Page, D. Postma, and M. Saetta Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 6 - 14. [Abstract] [Full Text] [PDF]

				S. Shahabuddin, R. Ji, P. Wang, E. Brailoiu, N. Dun, Y. Yang, M. O. Aksoy, and S. G. Kelsen CXCR3 chemokine receptor-induced chemotaxis in human airway epithelial cells: role of p38 MAPK and PI3K signaling pathways Am J Physiol Cell Physiol, July 1, 2006; 291(1): C34 - C39. [Abstract] [Full Text] [PDF]

				R O'Donnell, D Breen, S Wilson, and R Djukanovic Inflammatory cells in the airways in COPD Thorax, May 1, 2006; 61(5): 448 - 454. [Abstract] [Full Text] [PDF]

				M. O. Aksoy, Y. Yang, R. Ji, P. J. Reddy, S. Shahabuddin, J. Litvin, T. J. Rogers, and S. G. Kelsen CXCR3 surface expression in human airway epithelial cells: cell cycle dependence and effect on cell proliferation Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L909 - L918. [Abstract] [Full Text] [PDF]

				P. Pignatti, G. Brunetti, D. Moretto, M.-R. Yacoub, M. Fiori, B. Balbi, A. Balestrino, G. Cervio, S. Nava, and G. Moscato Role of the Chemokine Receptors CXCR3 and CCR4 in Human Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 310 - 317. [Abstract] [Full Text] [PDF]

				P. J. Barnes New approaches to COPD Eur. Respir. Rev., September 1, 2005; 14(94): 2 - 11. [Abstract] [Full Text] [PDF]

				J. C. L. Spurrell, S. Wiehler, R. S. Zaheer, S. P. Sanders, and D. Proud Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection Am J Physiol Lung Cell Mol Physiol, July 1, 2005; 289(1): L85 - L95. [Abstract] [Full Text] [PDF]

				T. Zheng, M. J. Kang, K. Crothers, Z. Zhu, W. Liu, C. G. Lee, L. A. Rabach, H. A. Chapman, R. J. Homer, D. Aldous, et al. Role of Cathepsin S-Dependent Epithelial Cell Apoptosis in IFN-{gamma}-Induced Alveolar Remodeling and Pulmonary Emphysema J. Immunol., June 15, 2005; 174(12): 8106 - 8115. [Abstract] [Full Text] [PDF]

				P. J. Barnes and R. A. Stockley COPD: current therapeutic interventions and future approaches Eur. Respir. J., June 1, 2005; 25(6): 1084 - 1106. [Abstract] [Full Text] [PDF]

				A. Baydur Not All That Comes Out Is Hot Air Chest, May 1, 2005; 127(5): 1482 - 1485. [Full Text] [PDF]

				E. F. M. Wouters Local and Systemic Inflammation in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2005; 2(1): 26 - 33. [Abstract] [Full Text] [PDF]

				P. J. Barnes Mediators of Chronic Obstructive Pulmonary Disease Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548. [Abstract] [Full Text] [PDF]

				P. K. Jeffery Remodeling and Inflammation of Bronchi in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 176 - 183. [Abstract] [Full Text] [PDF]

				S. N. Georas Inhaled Glucocorticoids, Lymphocytes, and Dendritic Cells in Asthma and Obstructive Lung Diseases Proceedings of the ATS, November 1, 2004; 1(3): 215 - 221. [Abstract] [Full Text] [PDF]

				M. D. Wareing, A. B. Lyon, B. Lu, C. Gerard, and S. R. Sarawar Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice J. Leukoc. Biol., October 1, 2004; 76(4): 886 - 895. [Abstract] [Full Text] [PDF]

				S. G. Kelsen, M. O. Aksoy, Y. Yang, S. Shahabuddin, J. Litvin, F. Safadi, and T. J. Rogers The chemokine receptor CXCR3 and its splice variant are expressed in human airway epithelial cells Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L584 - L591. [Abstract] [Full Text] [PDF]

				A. Di Stefano, G. Caramori, A. Capelli, I. Gnemmi, F.L. Ricciardolo, T. Oates, C.F. Donner, K.F. Chung, P.J. Barnes, and I.M. Adcock STAT4 activation in smokers and patients with chronic obstructive pulmonary disease Eur. Respir. J., July 1, 2004; 24(1): 78 - 85. [Abstract] [Full Text] [PDF]

				C. Pilette, J.N. Francis, S.J. Till, and S.R. Durham CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge Eur. Respir. J., June 1, 2004; 23(6): 876 - 884. [Abstract] [Full Text] [PDF]

				C. Schulz, K. Kratzel, K. Wolf, S. Schroll, M. Kohler, and M. Pfeifer Activation of Bronchial Epithelial Cells in Smokers Without Airway Obstruction and Patients With COPD Chest, May 1, 2004; 125(5): 1706 - 1713. [Abstract] [Full Text] [PDF]

				J. H. Ryu, J. L. Myers, and S. J. Swensen Bronchiolar Disorders Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1277 - 1292. [Abstract] [Full Text] [PDF]

				M. Saetta, S. Baraldo, and R. Zuin Neutrophil Chemokines in Severe Exacerbations of Chronic Obstructive Pulmonary Disease: Fatal Chemo-Attraction? Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 911 - 913. [Full Text] [PDF]

				Y. Qiu, J. Zhu, V. Bandi, R. L. Atmar, K. Hattotuwa, K. K. Guntupalli, and P. K. Jeffery Biopsy Neutrophilia, Neutrophil Chemokine and Receptor Gene Expression in Severe Exacerbations of Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 968 - 975. [Abstract] [Full Text] [PDF]

				P.J. Barnes, S.D. Shapiro, and R.A. Pauwels Chronic obstructive pulmonary disease: molecular and cellularmechanisms Eur. Respir. J., October 1, 2003; 22(4): 672 - 688. [Abstract] [Full Text] [PDF]

				B. Balbi COPD: Is Chemotaxis the Key? Chest, April 1, 2003; 123(4): 983 - 986. [Full Text] [PDF]

				M. J. Tobin Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 356 - 370. [Full Text] [PDF]

				L. M. Fabbri, M. Romagnoli, L. Corbetta, G. Casoni, K. Busljetic, G. Turato, G. Ligabue, A. Ciaccia, M. Saetta, and A. Papi Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 418 - 424. [Abstract] [Full Text] [PDF]